The opiate of the bosses By: MarketWatch November 14, 2017 at 14:16 PM EST The opioid crisis highlights the fundamental flaw in the argument that large-scale deregulation benefits societies, writes Lucy Marcus. Read More >> Related Stocks: Johnson & Johnson